Research Topics
| R J BattafaranoSummaryAffiliation: Washington University School of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Perioperative complications after living donor lobectomyR J Battafarano
Divisions of Cardiothoracic Surgery and Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO, USA
J Thorac Cardiovasc Surg 120:909-15. 2000..Living donor lobectomy provides right and left lower lobes from a pair of living donors for each recipient. We reviewed our experience with living donor lobectomy from July 1994 to February 2000...
Benefits of resection for metachronous lung cancerRichard J Battafarano
Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, One Barnes Jewish Plaza, 3108 Queeny Tower, St Louis, MO 63110, USA
J Thorac Cardiovasc Surg 127:836-42. 2004..The benefits of resection for metachronous lung cancer are not well described. The objective of this study was to evaluate the safety and efficacy of surgical resection for metachronous lung cancers...
Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancerRichard J Battafarano
Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, St Louis, MO 63110, USA
J Thorac Cardiovasc Surg 130:166-72. 2005..The objective of this study was to report the outcome of surgical resection in patients with large cell neuroendocrine carcinomas...
Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survivalRichard J Battafarano
Department of Surgery, Washington University School of Medicine, St Louis, Missouri 63110 1013, USA
Ann Thorac Surg 74:988-93; discussion 993-4. 2002..Consequently, these changes shifted the stage of patients with these lesions to stage IIIB or stage IV. The goal of this review was to determine the impact of multifocal non-small cell lung cancer on survival...
Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancerRichard J Battafarano
Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, St Louis, Mo 63110 1013, USA
J Thorac Cardiovasc Surg 123:280-7. 2002..The goal of this review was to determine the impact of comorbidity on postoperative and long-term survival after surgical resection in patients with stage I non-small cell lung cancer...
Lung transplantation is warranted for stable, ventilator-dependent recipientsB F Meyers
Department of Surgery, Washington University School of Medicine, St Louis, Missouri 63110 1013, USA
Ann Thorac Surg 70:1675-8. 2000..Lung transplantation for patients on ventilators is a controversial use of scarce donor lungs. We have performed 500 lung transplants in 12 years and 21 of these have been in ventilator-dependent patients...
A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancerBoone Goodgame
Division of Medical Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
Am J Clin Oncol 31:22-8. 2008..There are no reliable markers to predict recurrence in resected Stage I non-small cell lung cancer (NSCLC). A validated clinical model to estimate the risk of recurrence would help select patients for adjuvant therapy...
Large-cell neuroendocrine carcinoma of the lungFelix G Fernandez
Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA
Cancer Control 13:270-5. 2006..Efforts to identify effective adjuvant therapies are needed to improve treatment outcomes with this aggressive type of lung cancer...
Optimal management of patients with non-small cell lung cancer with ipsilateral mediastinal lymph node metastasesRichard J Battafarano
J Thorac Cardiovasc Surg 131:1227-8. 2006
Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancerBryan F Meyers
Division of Cardiothoracic Surgery, Washington University School of Medicine, Saint Louis, Missouri, USA
J Thorac Cardiovasc Surg 131:822-9; discussion 822-9. 2006....
Large-cell neuroendocrine carcinoma of the lung: an aggressive neuroendocrine lung cancerFelix G Fernandez
Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, MO, USA
Semin Thorac Cardiovasc Surg 18:206-10. 2006..This article reviews the tumor characterization, biology, presentation and diagnosis, surgical therapy, results of therapy, and long term prognosis of patients with LCNEC...
Lung cancer resection combined with lung volume reduction in patients with severe emphysemaCliff K Choong
Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, and Jacqueline Mariitz Lung Center at Barnes-Jewish Hospital, St Louis, MO 63110, USA
J Thorac Cardiovasc Surg 127:1323-31. 2004....
Endovascular lung perfusion using high-dose cisplatin: uptake and DNA adduct formation in an animal modelDaniel B Brown
Mallinckrodt Institute of Radiology, Alvin J Siteman Cancer Center, St Louis, MO 63110, USA
Oncol Rep 11:237-43. 2004..Further study of ELP evaluating the acute and chronic effects of repeated treatment administration is warranted...
Outcomes after resection of giant emphysematous bullaePaul H Schipper
Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA
Ann Thorac Surg 78:976-82; discussion 976-82. 2004..CONCLUSIONS: In a contemporary series, giant bullectomy is shown to produce significant immediate functional improvement. This benefit declines with time but persists at least 3 years...
Prevalence of benign disease in patients undergoing resection for suspected lung cancerMichael A Smith
Department of Surgery, Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, Missouri, USA
Ann Thorac Surg 81:1824-8; discussion 1828-9. 2006..Aggressive attempts to diagnose and treat early stage lung cancer must be tempered with this understanding...
Lung transplantation for lymphangioleiomyomatosisTaine T Pechet
Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, Missouri 63110, USA
J Heart Lung Transplant 23:301-8. 2004..Morbidity is common after transplant for lymphangioleiomyomatosis and is usually due to lymphangioleiomyomatosis-related complications. Lymphangioleiomyomatosis recurrence in the allograft does not pose a substantial clinical problem...
Thirteen-year experience in lung transplantation for emphysemaStephen D Cassivi
Division of Cardiothoracic Surgery, Washington University Medical Center, St. Louis, Missouri 63110-1013, USA
Ann Thorac Surg 74:1663-9; discussion 1669-70. 2002..Bilateral lung transplantation for emphysema results in better long-term survival. Accumulated experience and modifications in perioperative care over our 13-year series may explain recently improved early and long-term survival...
Does donor cause of death affect the outcome of lung transplantation?Anna Maria Ciccone
Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St Louis, MO 63110, USA
J Thorac Cardiovasc Surg 123:429-34; discussion 434-6. 2002..We conducted a retrospective analysis of our adult lung transplant experience to investigate the influence of donor traumatic brain injury versus nontraumatic brain injury on posttransplantation outcome...
Management of complications of lung resection. IntroductionRichard J Battafarano
Semin Thorac Cardiovasc Surg 19:342. 2007
